![](/img/cover-not-exists.png)
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer
Elaine T. Lam, Jessie L.- S. Au, Gregory A. Otterson, M. Guillaume Wientjes, Ling Chen, Tong Shen, Yong Wei, Xiaobai Li, Tanios Bekaii-Saab, Anthony J. Murgo, Rhonda R. Jensen, Michael Grever, MiguelVolume:
66
Language:
english
Pages:
11
DOI:
10.1007/s00280-010-1252-x
Date:
November, 2010
File:
PDF, 422 KB
english, 2010